Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
The American Journal of Pathology
|
July 11, 2002
Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells
Ronald J C L M Vuylsteke, Paul A M van Leeuwen, Sybren Meijer, et al.
Journal for Immunotherapy of Cancer
|
October 13, 2020
Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
Kim M van Pul, Ronald J C L M Vuylsteke, Monique T A de Beijer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content
Ronald J C L M Vuylsteke, Barbara G Molenkamp, Paul A M van Leeuwen, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
Kim M van Pul, Ronald J C L M Vuylsteke, Rieneke van de Ven, et al.
Annals of Surgical Oncology
|
May 3, 2005
Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma
Ronald J C L M Vuylsteke, Paul J Borgstein, Paul A M van Leeuwen, et al.
Cancer Research
|
November 19, 2004
Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma
Ronald J C L M Vuylsteke, Barbara G Molenkamp, Hester A Gietema, et al.
Immunobiology
|
August 22, 2006
Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients
Steven J Oosterling, Anneke K Mels, Teunis B H Geijtenbeek, et al.
Surgical Endoscopy
|
March 20, 2019
Structured training pathway and proctoring; multicenter results of the implementation of transanal total mesorectal excision (TaTME) in the Netherlands
M Veltcamp Helbach, S E van Oostendorp, T W A Koedam, et al.
Oncoimmunology
|
February 1, 2020
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma
Bas D Koster, Tamarah D de Jong, Mari F C M van den Hout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials
Bas D Koster, Mari F C M van den Hout, Berbel J R Sluijter, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
The American Journal of Pathology
|
July 11, 2002
Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells
Ronald J C L M Vuylsteke, Paul A M van Leeuwen, Sybren Meijer, et al.
Journal for Immunotherapy of Cancer
|
October 13, 2020
Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
Kim M van Pul, Ronald J C L M Vuylsteke, Monique T A de Beijer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content
Ronald J C L M Vuylsteke, Barbara G Molenkamp, Paul A M van Leeuwen, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
Kim M van Pul, Ronald J C L M Vuylsteke, Rieneke van de Ven, et al.
Annals of Surgical Oncology
|
May 3, 2005
Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma
Ronald J C L M Vuylsteke, Paul J Borgstein, Paul A M van Leeuwen, et al.
Cancer Research
|
November 19, 2004
Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma
Ronald J C L M Vuylsteke, Barbara G Molenkamp, Hester A Gietema, et al.
Immunobiology
|
August 22, 2006
Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients
Steven J Oosterling, Anneke K Mels, Teunis B H Geijtenbeek, et al.
Surgical Endoscopy
|
March 20, 2019
Structured training pathway and proctoring; multicenter results of the implementation of transanal total mesorectal excision (TaTME) in the Netherlands
M Veltcamp Helbach, S E van Oostendorp, T W A Koedam, et al.
Oncoimmunology
|
February 1, 2020
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma
Bas D Koster, Tamarah D de Jong, Mari F C M van den Hout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials
Bas D Koster, Mari F C M van den Hout, Berbel J R Sluijter, et al.
Page
of 5